Skip to content

Lung Cancer Health Center

Font Size

Small Cell Lung Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage Information for Small Cell Lung Cancer

Staging Systems

Several staging systems have been proposed for small cell lung cancer (SCLC). These staging systems include the following:

Recommended Related to Lung Cancer

Questions to Ask About Your Lung Cancer

1. Exactly what kind of lung cancer do I have? 2. Where is the cancer located and how far has it spread? What stage is my cancer? 3. What are my chances for recovery? 4. Can you surgically remove my lung cancer? 5. How will the surgery affect my breathing or quality of life? 6. Will I need chemotherapy or radiotherapy? 7. What are the goals of these lung cancer treatments, and...

Read the Questions to Ask About Your Lung Cancer article > >

  • American Joint Committee on Cancer (AJCC) Tumor, Node, and Metastasis (TNM).[1]
  • Veterans Administration Lung Study Group (VALG).[2]
  • International Association for the Study of Lung Cancer (IASLC).[3]

Limited-Stage Disease

No universally accepted definition of this term is available. Limited-stage disease (LD) SCLC is confined to the hemithorax of origin, the mediastinum, or the supraclavicular nodes, which can be encompassed within a tolerable radiation therapy port.

Patients with pleural effusion, massive pulmonary tumor, and contralateral supraclavicular nodes have been both included within and excluded from LD by various groups.

Extensive-Stage Disease

Extensive-stage disease (ED) SCLC has spread beyond the supraclavicular areas and is too widespread to be included within the definition of LD. Patients with distant metastases (M1) are always considered to have ED.[3,4]

IASLC-AJCC TNM Staging System

The AJCC TNM defines LD as any T, except for T3-4, due to multiple lung nodals that do not fit in a tolerable radiation field, any N, and M0.[1] This corresponds to TNM stages I to IIIB. Extensive disease is TNM stage IV with distant metastases (M1) including malignant pleural effusions.[3,4]

The IASLC conducted an analysis of clinical TNM staging for SCLC using the sixth edition of the AJCC TNM staging system for lung cancer. Survivals for patients with clinical stages I and II disease are significantly different from those for patients with stage III disease with N2 or N3 involvement.[3] Patients with pleural effusion have an intermediate prognosis between LD and ED with hematogenous metastases and will be classified as having M1 disease (or ED). Application of the TNM system will not change how patients are managed; however, the analysis suggests that, in the context of clinical trials in LD, accurate TNM staging and stratification may be important.[3]

Staging Evaluation

Staging procedures for SCLC are important in distinguishing patients with disease limited to their thorax from those with distant metastases. At the time of initial diagnosis, approximately two-thirds of patients with SCLC have clinical evidence of metastases; most of the remaining patients have clinical evidence of extensive nodal involvement in the hilar, mediastinal, and sometimes supraclavicular regions.

    1|2
    Next Article:

    Today on WebMD

    Broken cigarette
    Do you know the myths from the facts?
    man with a doctor
    Our health check will steer you in the right direction.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    15 Cancer Symptoms Men Ignore
    FEATURE
    Lung Cancer Risks Myths and Facts
    SLIDESHOW
     
    cancer fighting foods
    SLIDESHOW
    Improving Lung Cancer Survival Targeted Therapy
    VIDEO
     
    Lung Cancer Surprising Differences Between Sexes
    VIDEO
    Pets Improve Your Health
    SLIDESHOW
     
    Vitamin D
    SLIDESHOW
    Lung Cancer Surgery Options
    VIDEO
     

    WebMD Special Sections